Artimplant - Key ratios

News

Year-end report conference call February 11 at 11 AM (CET) >>

Read the CEO interview at redeye.se - December 12, 2009 (in Swedish) >>

Meet us at:

AAOS 2010 >>
New Orleans, United States
March 9 – 13, 2010
Booth no: 5318

Annual report

Key ratios

Amounts in SEK thousands	Jan-Dec 2008	Jan-Dec 2007	Jan-Dec 2006	Jan-Dec 2005	Jan-Dec 2004
Equity per stock unit, SEK	0,71	1.08	1.31	2.24	2.13
Equity per stock unit after dilution, SEK	0,71	1.08	1.31	2.24	2.13
Loss per stock unit, SEK	-0,38	-0.23	-0.95	-0.73	-1.12
Loss per stock unit after dilution, SEK	-0,38	-0.23	-0.95	-0.73	-1.12
No. of stock units in issue at year-end	59,244,790	59,244,790	59,244,790	59,244,790	39,496,527
Average no. of stock units in issue during year	59,244,790	59,244,790	59,244,790	49,370,659	37,696,527
No. of stock units in issue after dilution	60,793,246	60,446,582	60,348,628	61,107,012	40,829,867
Cash flow per stock unit, SEK	-0,30	-0.33	-0.60	0.89	-0.42
Dividend per stock unit, SEK¹	-	-	-	-	-
Market price, highest, SEK	4,25	7.55	9.80	9.15	15.40
Market price, lowest, SEK	1,55	3.10	2.79	4.29	3.67
Market price as of Jan 1, SEK	3,32	3.66	8.45	6.50	7.60
Market price as of Dec 31, SEK	1,64	3.32	3.66	8.45	6.50
Return on equity, %	Neg	Neg	Neg	Neg	Neg
Return on capital employed, %	Neg	Neg	Neg	Neg	Neg
Equity/assets ratio %	89	92	93	95	91
Proportion of risk capital, %	89	92	93	95	91
Interest bearing liabilities	None	None	None	None	None
Interest coverage ratio, times	Neg	Neg	Neg	Neg	Neg
Financial net assets	31,371	49,240	68,704	104,186	51,277
Capital expenditure
Research and development²	-	-	480	1,587	2,889
Patents and brands	471	3,236	646	574	367
Machinery, equipment and fixed assest under construction	129	627	1,165	1,141	651
Number of employees
No. of employees as of Dec 31	28	25	28	27	26

The impact of dilution has not been reported in those cases where dilution would have resulted in an improvement in the key ratios.

1) For 2008, the figure refers to the proposal by the Board of Directors.

2) Investment in product development according to IAS 38. With effect from 2007, product development expenses are not capitalized.